What is the price target for CHYM stock?
22 analysts have analysed CHYM and the average price target is 32.78 USD. This implies a price increase of 67.14% is expected in the next year compared to the current price of 19.61.
NASDAQ:CHYM • US16935C1099
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHIME FINANCIAL INC-CL A (CHYM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | Keybanc | Initiate | Overweight |
| 2026-02-26 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-26 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-26 | Rothschild & Co | Initiate | Neutral |
| 2026-01-06 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-12-11 | B. Riley Securities | Initiate | Buy |
| 2025-12-01 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-03 | Jefferies | Initiate | Hold |
| 2025-10-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-13 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-10-01 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-08-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-17 | Deutsche Bank | Reiterate | Hold |
| 2025-07-08 | Keefe, Bruyette & Woods | Initiate | Outperform |
| 2025-07-07 | William Blair | Initiate | Outperform |
| 2025-07-07 | Wolfe Research | Initiate | Outperform |
| 2025-07-07 | UBS | Initiate | Neutral |
| 2025-07-07 | Barclays | Initiate | Overweight |
| 2025-07-07 | Evercore ISI Group | Initiate | Outperform |
| 2025-07-07 | JP Morgan | Initiate | Overweight |
| 2025-07-07 | Canaccord Genuity | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.278B 26.73% | 1.673B 30.88% | 2.187B 30.69% | 2.706B 23.74% | 3.223B 19.11% | 3.764B 16.79% | |
| EBITDA YoY % growth | -222.848M 52.73% | -36.829M 83.47% | -1.01B -2,642.35% | 399.22M 139.53% | 626.28M 56.88% | 907.63M 44.92% | |
| EBIT YoY % growth | -235.785M 50.74% | -62.199M 73.62% | -1.04B -1,572.02% | 178.81M 117.19% | 420.59M 135.22% | 772.85M 83.75% | |
| Operating Margin | -18.44% | -3.72% | -47.56% | 6.61% | 13.05% | 20.53% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.15 103.20% | 0.63 326.03% | 1.04 64.31% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.02 | -0.02 99.68% | 0.05 136.04% | 0.10 179.90% | 0.17 638.64% | 0.12 605.43% | 0.17 220.75% | 0.22 126.06% | 0.23 41.54% | 0.19 59.14% | 0.27 55.88% | 0.33 52.94% |
| Revenue Q2Q % growth | 648.1M 24.94% | 653.85M 23.80% | 676.3M 24.43% | 725.74M 21.70% | 764.55M 17.97% | 775.24M 18.57% | 799.76M 18.26% | 856.06M 17.96% | 900.02M 17.72% | 907.06M 17.00% | 933.66M 16.74% | 1.005B 17.40% |
| EBITDA Q2Q % growth | 92.418M 463.70% | 79.765M 108.71% | 103.52M 343.42% | 121.42M 610.85% | 144.67M 56.54% | 128.85M 61.54% | 150.29M 45.18% | 177.21M 45.95% | 222.21M 53.60% | 204.08M 58.39% | 232.16M 54.47% | 269.32M 51.98% |
| EBIT Q2Q % growth | 39.696M 334.45% | 23.799M 102.56% | 64.424M 199.56% | 85.284M 258.61% | 105.77M 166.45% | 90.896M 281.93% | 117.69M 82.68% | 151.01M 77.07% | 206.38M 95.12% | 188.05M 106.88% | 227.34M 93.17% | 266.49M 76.47% |
All data in USD
22 analysts have analysed CHYM and the average price target is 32.78 USD. This implies a price increase of 67.14% is expected in the next year compared to the current price of 19.61.
CHIME FINANCIAL INC-CL A (CHYM) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of CHIME FINANCIAL INC-CL A (CHYM) is 0.02 USD and the consensus revenue estimate is 648.10M USD.
The consensus rating for CHIME FINANCIAL INC-CL A (CHYM) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.